Clinical Trials Logo

Adult Brain Tumors clinical trials

View clinical trials related to Adult Brain Tumors.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00387894 Terminated - Adult Brain Tumors Clinical Trials

Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Start date: January 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well erlotinib works in treating patients with recurrent glioblastoma multiforme or gliosarcoma.